Diabetes mellitus is considered a relative contra-indication for implant therapy. However, the effect of glycemic level on implant integration in persons with diabetes remains poorly understood. The hypothesis of this research was that poor glycemic control is directly related to short-term-impairment implant stabilization. This prospective clinical study evaluated 10 non-diabetic individuals (12 implants) and 20 persons with type 2 diabetes (30 implants). Glycated hemoglobin (HbA1c) levels ranged from 4.7–12.6%. Implant stability was assessed by resonance frequency analysis over 4 months following placement. Minimum stability levels were observed 2–6 weeks following placement for all 42 implants. Persons with HbA1c ≥ 8.1% had a greater maximum decrease in stability from baseline and required a longer time for healing, as indicated by return of stability level to baseline. This study demonstrates alterations in implant stability consistent with impaired implant integration for persons with type 2 diabetes mellitus in direct relation to hyperglycemic conditions.
Get full access to this article
View all access options for this article.
References
1.
Abdulwassie H, Dhanrajani PJ -2002-. Diabetes mellitus and dental implants: a clinical study. Implant Dent11:83–86.
2.
Amir G, Rosenmann E, Sherman Y, Greenfeld Z, Ne’eman Z, Cohen AM -2002-. Osteoporosis in the Cohen diabetic rat: correlation between histomorphometric changes in bone and microangiopathy. Lab Invest82:1399–1405.
3.
Barewal RM, Oates TW, Meredith N, Cochran DL -2003-. Resonance frequency measurement of implant stability in vivo on implants with a sandblasted and acid-etched surface. Int J Oral Maxillofac Implants18:641–651.
4.
Beam HA, Parsons JR, Lin SS -2002-. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res20:1210–1216.
5.
Beikler T, Flemmig TF -2003-. Implants in the medically compromised patient. Crit Rev Oral Biol Med14:305–316.
6.
Blanchaert RH -1998-. Implants in the medically challenged patient. Dent Clin North Am42:35–45.
7.
Derr R, Garrett E, Stacy GA, Saudek CD -2003-. Is HbA-1c- affected by glycemic instability? Diabetes Care26: 2728–2733.
8.
The Diabetes Control and Complications Trial -DCCT- Research Group -1993-. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med329:977–986.
9.
Dowell S, Oates TW, Robinson M -2007-. A pilot study of implant success in individuals with type 2 diabetes mellitus with varying glycemic control. J Am Dent Assoc138:355–361.
10.
Fiorellini JP, Chen PK, Nevins M, Nevins ML -2000-. A retrospective study of dental implants in diabetic patients. Int J Periodontics Restorative Dent20:366–373.
11.
Follak N, Kloting L, Wolf E, Merk H -2004-. Delayed remodeling in the early period of fracture healing in spontaneously diabetic BB/OK rats depending on the diabetic metabolic state. Histol Histopathol19:473–486.
12.
Friberg B, Sennerby L, Meredith N, Lekholm U -1999-. A comparison between cutting torque and resonance frequency measurements of maxillary implants. Int J Oral Maxillofac Surg28:297–303.
13.
Funk JR, Hale JE, Carmines D, Gooch HL, Hurwitz SR -2000-. Biomechanical evaluation of early fracture healing in normal and diabetic rats. J Orthop Res18:126–132.
14.
Garrett NR, Kapur KK, Hamada MO, Roumanas ED, Freymiller E, Han T, et al. -1998-. A randomized clinical trial comparing the efficacy of mandibular implant-supported overdentures and conventional dentures in diabetic patients: Part II. Comparisons of masticatory performance. J Prosthet Dent79:632–640.
15.
Gebauer GP, Lin SS, Beam HA, Vieira P, Parsons JR -2002-. Low-intensity pulsed ultrasound increases the fracture callus strength in diabetic BB Wistar rats but does not affect cellular proliferation J Orthop Res20:587–592.
16.
Gerritsen M, Lutterman JA, Jansen JA -2000-. Wound healing around bone-anchored percutaneous devices in experimental diabetes mellitus. J Biomed Mater Res53:702–709.
17.
Gooch HL, Hale JE, Fujioka H, Balian G, Hurwitz SR -2000-. Alterations of cartilage and collagen expression during fracture healing in experimental diabetes. Connect Tissue Res41:81–85.
18.
He H, Liu R, Desta T, Leone C, Gerstenfeld LC, Graves DT -2004-. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology145:447–452.
19.
Kayal RA, Tsatsas D, Bauer MA, Allen B, Al-Sebaei MO, Kakar S, et al. -2007-. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res22:560–568.
20.
Kirk JK, Bell RA, Bertoni AG, Arcury TA, Quandt SA, Goff DC Jr, et al. -2005-. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with Type 2 diabetes. Ann Pharmacother39:1489–1501.
21.
Lekholm U, Zarb G -1985-. Patient selection and preparation. In: Tissue integrated prostheses: osseointegration in clinical dentistry. Brånemark PI, Albrektsson T, Zarb G, editors. Chicago, IL: Quintessence, pp. 199–210.
22.
Liang KY, Zeger SL -1986-. Longitudinal data analysis using generalized linear models. Biometrika73:13–22.
23.
Liu R, Bal HS, Desta T, Behl Y, Graves DT -2006-. Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. Am J Pathol168:757–764.
24.
Loder RT -1988-. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res232:210–216.
25.
Lu H, Kraut D, Gerstenfeld LC, Graves DT -2003-. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology144:346–352.
26.
McCracken M, Lemons JE, Rahemtulla F, Prince CW, Feldman D -2000-. Bone response to titanium alloy implants placed in diabetic rats. Int J Oral Maxillofac Implants15:345–351.
27.
Meredith N, Alleyne D, Cawley P -1996-. Quantitative determination of the stability of the implant-tissue interface using resonance frequency analysis. Clin Oral Implants Res7:261–267.
28.
Meredith N, Book K, Friberg B, Jemt T, Sennerby L -1997a-. Resonance frequency measurements of implant stability in vivo. Clin Oral Implants Res8:226–233.
29.
Meredith N, Shagaldi F, Alleyne D, Sennerby L. Cawley P -1997b-. The application of resonance frequency measurements to study the stability of titanium implants during healing in the rabbit tibia. Clin Oral Implants Res8:234–243.
30.
Morris HF, Ochi S, Winkler S -2000-. Implant survival in patients with type 2 diabetes: placement to 36 months. Ann Periodontol5:157–165.
31.
Moy P, Medina D, Shetty V, Aghaloo T -2005-. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants20:569–577.
32.
Nevins ML, Karimbux NY, Weber HP, Giannobile WV, Fiorellini JP -1998-. Wound healing around endosseous implants in experimental diabetes. Int J Oral Maxillofac Implants13:620–629.
33.
Olson JW, Shernoff AF, Tarlow JL, Colwell JA, Scheetz JP, Bingham SF -2000-. Dental endosseous implant assessments in a type 2 diabetic population: a prospective study. Int J Oral Maxillofac Implants15:811–818.
34.
Shernoff AF, Colwell JA, Bingham SF -1994-. Implants for type 2 diabetic patients: interim report. Implant Dent3:183–189.
35.
United Kingdom Prospective Diabetes Study -UKPDS- Group -2000-. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes -UKPDS 35-. BMJ321:405–412.
36.
White CB, Turner NS, Lee GC, Haidukewych GJ -2003-. Open ankle fractures in patients with diabetes mellitus. Clin Orthop Relat Res414:37–44.
37.
World Workshop in Periodontics -1996-. Consensus report. Implant therapy II. Ann Periodontol1:816–820.
